Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Blood PressureCognition
Interventions
DRUG

Placebo

Study subjects received, in a double blind fashion, placebo pills identical to the drug (drug 1-ginseng, group 1; drug 2-ginkgo biloba-group 2)

DRUG

Ginseng

The ginseng group received two capsules containing either 1000 mg or 500 mg of Panax Ginseng extract standardized to 3% of ginsenosides (GNC, USA) or similarly looking placebo capsules over a period of three days of testing.

DRUG

Ginkgo Biloba

The ginkgo group received two capsules containing either 240 mg or 120 mg of ginkgo biloba extract standardized to 24% ginkgo flavone glycosides and 6% terpene lactones (GBE24/6) or similarly looking placebo capsules over a period of three testing days.

Trial Locations (1)

47500

Department of Psychology, Sunway University, Sunway City

All Listed Sponsors
lead

Sunway University

OTHER

NCT02386852 - Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity | Biotech Hunter | Biotech Hunter